Cardiac Troponin T molecules in ESRD patients are smaller (<18 kDa) than those in AMI patients, which could inform the development of more specific diagnostic immunoassays.
No takes yet. Share an insight, caveat, or question.
May confound troponin interpretation in ESRD; extends molecular data to guide ESRD-specific immunoassay development.
Mingels et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: